Butalbital Impurity 2

INQUIRY Add to cart

For Research Use Only | Not For Clinical Use

CAT	APB215363114
CAS	215363-11-4
Molecular Weight	222.24
Molecular Formula	C11H14N2O3

What is the product name of CAS 215363-11-4?

The product name is Butalbital Impurity 2.

What is the molecular weight of Butalbital Impurity 2?

The molecular weight is 222.24.

What is the molecular formula of Butalbital Impurity 2?

The molecular formula is C11H14N2O3.

What is the chemical structure of Butalbital Impurity 2?

The chemical structure is C-C-C-C-C-C-N-C-C-O-C-OH.

What is the role of Butalbital Impurity 2 in pharmaceuticals?

Butalbital Impurity 2 is a potential impurity in pharmaceutical formulations containing butalbital.

How is Butalbital Impurity 2 detected in pharmaceutical products?

Butalbital Impurity 2 is detected using analytical techniques such as HPLC and LC-MS.

What are the common sources of Butalbital Impurity 2 in drug manufacturing?

Butalbital Impurity 2 can be sourced from starting materials, intermediates, or degradation products during drug synthesis.

How does the presence of Butalbital Impurity 2 affect the quality of pharmaceutical products?

The presence of Butalbital Impurity 2 can affect the purity, potency, and stability of pharmaceutical products.

What steps can be taken to minimize the formation of Butalbital Impurity 2 during drug manufacturing?

Proper process optimization, impurity identification, and monitoring are essential steps to minimize the formation of Butalbital Impurity 2.

What regulatory guidelines govern the presence of impurities such as Butalbital Impurity 2 in pharmaceutical products?

Regulatory authorities such as the FDA and EMA provide guidelines on acceptable levels of impurities, including Butalbital Impurity 2, in pharmaceutical products.

* Products or Services Interested: Butalbital Impurity 2 (215363-11-4)
* Your question
* Name
* Email
Verification Code

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.

Online Inquiry